Neuropilin-1 (NRP-1) and Magnetic Nanoparticles, a Potential Combination for Diagnosis and Therapy of Gliomas

Author(s): Lukui Chen, Guilong Zhang, Yan Shi, Rong Qiu, Ahsan Ali Khan

Journal Name: Current Pharmaceutical Design

Volume 21 , Issue 37 , 2015

Become EABM
Become Reviewer
Call for Editor


In this review, Neuropilin-1 (NRP-1) has been focused as a novel molecular target for potential treatment of gliomas. The properties of NRP-1 were described briefly. The role of NRP-1 in gliomas was explored in details, including relationships of NRP-1 expression and glioma prognosis, Sema3A-NRP-1 signaling in gliomas, NRP-1 signaling and VEGF/VEGFR、PlGF、TGF-β、PDGF、LD22-4 of FGF2、autocrine of HGF/SF、p130Cas tyrosine phosphorylation and integrin-associated tumor microenvironment in gliomas, NRP-1 intracellular trafficking, NRP-1 and glioma stem-like cells, as well as magnetic nanoparticles related to targeting gliomas. NRP-1, a multifunctional-receptors protein, would mediate diverse cellular signaling pathways in gliomas, and might potentially act as a novel therapeutic target. In future, magnetic nanoparticles coated with NRP-1 may play a vital role on diagnosis and therapy of gliomas.

Keywords: Neuropilin-1, glioma, magnetic nanoparticle, glioma stem cell, trafficking, gene therapy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 04 November, 2015
Page: [5434 - 5449]
Pages: 16
DOI: 10.2174/1381612821666150917092658
Price: $65

Article Metrics

PDF: 43